首页> 中文期刊>糖尿病新世界 >复方樟柳碱治疗糖尿病视网膜血管病变的疗效探讨

复方樟柳碱治疗糖尿病视网膜血管病变的疗效探讨

     

摘要

Objective To analyze the curative effect of compound anisodine in the treatment of diabetic retinal vascular le-sions. Methods A retrospective analysis was conducted on the clinical data of 112 cases with diabetic retinal vascular le-sions admitted in our hospital from July 2014 to July 2015. The patients were divided into two groups, the control group(50 cases) and the study group(62 cases) in accordance with the treatment regimen. Patients in the control group were given the conventional treatment, while those in the study group were treated by compound anisodine. And the total amplitude of BC-VA, OPS and CS of the two groups were compared before and after treatment. Results After treatment, the BCVA was im-proved in both groups, and the improvement was more significant in the study group with statistically significant differences (P<0.05). The total amplitude of OPS was improved in both groups after treatment, and the improvement was more signifi-cant in the study group with statistically significant differences (P<0.05). The CS in each segment was improved in both groups after treatment, and the improvement was more significant in the study group with statistically significant differences (P<0.05). Conclusion The curative effect of compound anisodine is significant in the treatment of diabetic retinal vascular lesions.%目的:分析复方樟柳碱治疗糖尿病视网膜血管病变的疗效。方法回顾性的选择2014年7月—2015年7月该院收治112例糖尿病视网膜血管病变(DR)患者临床资料,根据治疗时所采用不同方案分为两组,对照组50例行常规治疗,研究组62例行复方樟柳碱治疗,比较两组治疗前后BCVA、OPS总振幅及CS。结果两组BCVA均较治疗前有所改善,且研究组改善优于对照组;治疗后,两组OPS总振幅均较治疗前有所改善,且研究组改善优于对照组;治疗后,两组各段CS均较治疗前有所改善,且研究组改善效果优于对照组,两组比较差异有统计学意义(P<0.05)。结论复方樟柳碱治疗糖尿病视网膜血管病变的疗效显著。

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号